首页> 外文期刊>世界中西医结合杂志(英文) >Expert Consensus on Integrated Traditional and Western Medicine Prevention and Rehabilitation of Malignant Tumor During the Epidemics of Coronavirus Disease 2019(First Edition)Specialty Committee of Classical TCM Formula for Cancer Treatment and Research of World Federation of Chinese Medicine Societies
【24h】

Expert Consensus on Integrated Traditional and Western Medicine Prevention and Rehabilitation of Malignant Tumor During the Epidemics of Coronavirus Disease 2019(First Edition)Specialty Committee of Classical TCM Formula for Cancer Treatment and Research of World Federation of Chinese Medicine Societies

机译:关于癌症病毒疾病的流行病综合和西医预防和康复的专家共识2019年(第一版)癌症治疗古典中医公式专业委员会及其中医协会联合会

获取原文
获取原文并翻译 | 示例
       

摘要

Coronavirus Disease 2019(COVID-19)has caused a global outbreak and become a major public health issue.On January 20,2020,the announcement of National Health Commission(No.1 of 2020)included COVID-19 as a category B infectious disease in Law of the People''s Republic of China on prevention and control of Infectious Diseases,and took preventing and controlling measures like those of category A infectious diseases~([1]).Tumor patients are more susceptible to infection because of their vulnerable nutritional state and systemic immunosuppressive state caused by antitumor treatments,such as radiotherapy,chemotherapy and surgery~([2]).Cancer patients had an estimated 2-fold increased risk of COVID-19 than the general population according to the Report of the WHO-China Joint Mission on COVID-19~([3]);The incidence rate of COVID-19 in cancer patients in Wuhan is 0.79%,while the general population is 0.37%in the same period~([4]).And the COVID-19 cancer patients were with higher risk to become severe condition and worse prognosis,especially in those patients who received chemotherapy or surgery recently,than those without cancer~([5-6]).In addition,the inconvenience for patients going out to see doctors also leads to the delay of diagnosis and treatment.As a result,under the current severe situation,scientific and effective management measures and reasonable responsive strategies are urgently needed to minimize the impact of the epidemic on tumor patients~([7-9]).Especially recently,the outbreak continues to spread in many countries around the world.World Health Organization(WHO)believes the COVID-19 epidemic has the characteristics of a pandemic,calling on all countries to take urgent and active action.Under such circumstances,experts organized by Classical Traditional Chinese Medicine Prescription for Cancer Treatment and Research Committee of World Federation of Chinese Medicine Societies,discussed and formed"Expert Consensus on Integrated Traditional and Western Medicine Prevention and Rehabilitation During the Epidemics of Coronavirus Disease 2019",according to national prevention and treatment experience of COVID-19,especially in Wuhan.This consensus aims to provide a model for TCM experts around the world to guide tumor patients to respond reasonably and safely through COVID-19.Thoroughly taking advantages of integrated Chinese and Western medicine in diagnosis and treatment can minimize the adverse effects of the epidemic on patients with malignant tumors.
机译:2019年冠状病毒疾病(Covid-19)造成了全球爆发,成为一个主要的公共卫生问题。20020年1月20日,国家卫生委员会(2020年的第1号第1份)包括Covid-19作为B类传染病在中华人民共和国的预防和控制传染病的法律上,并采取了预防和控制等类别的传染病〜([1])。由于他们的脆弱,肿瘤患者更容易感染感染由抗肿瘤治疗引起的营养状态和全身免疫抑制状态,如放射疗法,化疗和手术〜([2])。癌症患者的Covid-19风险估计增加到普通人的普通人数 - Covid-19〜([3])上的中国联合任务;武汉癌症患者的Covid-19发生率为0.79%,而一般人群在同一时期为0.37%〜([4])。和covid-19癌症患者的风险较高,成为s威力病情和更糟糕的预后,特别是在最近接受化疗或手术的那些患者,而不是没有癌症的患者〜([5-6])。此外,患者出门的不便,看看医生也会导致诊断延迟和延迟治疗。在目前的严峻形势下,迫切需要进行科学和有效的管理措施和合理的反应策略,以尽量减少对肿瘤患者的影响〜([7-9])。特别是最近,爆发仍然存在在世界各地的许多国家传播。世界卫生组织(世卫组织)相信Covid-19流行病具有大流行的特点,呼吁所有国家采取紧急和积极的行动。在这种情况下,由古典中医处方组织的专家中国医学社会联合会的癌症治疗和研究委员会,讨论和成立了“关于综合传统和西医的专家共识2019年Coronavirus疾病的流行病中的预防和康复“,根据Covid-19的国家预防和治疗经验,特别是在武汉。这一共识旨在为世界各地的TCM专家提供一种模型,以指导肿瘤患者合理和安全地应对肿瘤患者通过Covid-19.在诊断和治疗中采取综合中西和西医的优势可以最大限度地减少疫情对恶性肿瘤患者的不利影响。

著录项

  • 来源
    《世界中西医结合杂志(英文)》 |2020年第003期|P.70-78|共9页
  • 作者单位

    Department of Chinese Medicine National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100021 China;

    Department of Respiratory Disease Beijing Hospital of Traditional Chinese Medicine Capital Medical University;

    Department of Oncology Wuhan No.1 Hospital;

    Department of Traditional Chinese Medicine Union Hospital Tongji Medical College of Huazhong University of Science and Technology;

    Department of Chinese with Western Medicine Zhongnan Hospital of Wuhan University Wuhan China;

    Department of Oncology Shanxi Hospital of Traditional Chinese Medicine;

    Department of Oncology The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine;

    Center for Integrative Therapies Dana-Farber Cancer Institute Harvard Medical School;

    Central Taiwan University of Science and Technology Department of Traditional Chinese Medicine Fengyuan Hospital of Health Promotion Administration of Taiwan China;

    French Federation of Digestive Cancer;

    Department of Chinese Medicine National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100021 China;

    Department of Chinese Medicine National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100021 China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 肿瘤学;
  • 关键词

    COVID-19; Oncology; Traditional Chinese Medicine;

    机译:covid-19;肿瘤学;中医;
  • 入库时间 2022-08-19 04:49:16
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号